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Background: Locally delivered doxycycline is found to be effective in managing periodontitis as an
adjunct to scaling and root planing.
Aim: To evaluate the effect of locally delivered doxycycline (10%) with scaling and root planing in
the periodontal treatment of smokers and to compare it with scaling and root planing alone.
Methods: Twelve smokers with chronic periodontitis and a pocket depth (P5 mm) on posterior
teeth that bleed on probing were selected. Patients were randomly assigned to scaling and root plan-
ing (SRP) or scaling and root planing followed by local application of doxycycline (SRP-D). Pla-
que, bleeding on probing, gingival recession, clinical attachment level (CAL), and probing depth
(PD) were recorded at the baseline, 6 and 12 weeks.
Results: Both groups showed a signiﬁcant reduction in Plaque, Bleeding on Probing and pocket
depth at 6th and 12th week from the baseline. A statistically signiﬁcant gain of attachment was
observed in both groups after treatment. Even though the doxycycline group showed slightly higher
attachment gain it was not statistically signiﬁcant compared to the control group.ivision of Periodontics and
tistry, King Saud University,
rabia. Tel.: +966 505292843.
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144 H. Al Hulami et al.Conclusion: The observations of the study reveal that the additional beneﬁt of topical application
of doxycycline as an adjunct to scaling and root planing in smokers is not convincing. However,
further clinical studies may be necessary to substantiate the present observations.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Periodontitis is a chronic inﬂammatory condition character-
ized by acute episodes of periodontal destruction occurring
in response to an elevated bacterial load in a susceptible host
(Offenbacher, 1996; Page, 1995). The successful long-term
management of periodontitis may require an integrated treat-
ment approach that addresses both the periodontopathic bac-
teria and the ensuing destructive host responses. Previous
studies have demonstrated that topically administrated doxy-
cycline improves some clinical parameters in patients with
adult periodontitis (Caton et al., 2000; Ciancio and Ashley,
1998; Crout et al., 1996).
Subgingival scaling and root planing (SRP) is an effective
means of slowing or arresting periodontal disease progression
(Badersten et al., 1984a; Pihlstrom et al., 1983). The beneﬁcial
effects of SRP, which include gains in clinical attachment and
reductions in probing depth (PD) and clinical inﬂammation,
arise from a reduction in the microbial burden in the periodon-
tal pocket or a shift toward less pathogenic microﬂora. How-
ever, the efﬁcacy of SRP may be compromised at tooth sites
with deep pockets and at sites with furcation involvements.
Furthermore, the long-term success of SRP may be affected
by remaining bacterial virulence factors and ineffective
personal plaque control (Caton et al., 2000).
Smoking is known as a major risk factor for increasing the
prevalence and severity of periodontal destruction (Papapanou,
1996). It accelerates the progression of periodontitis and jeopar-
dizes the healing process following non-surgical periodontal
therapy (Grossi et al., 1996; Johnson and Hill, 2004; Preber
and Bergstrom, 1986). The non-surgical periodontal therapy
eliminates or suppresses the putative periodontal microorgan-
isms in the subgingival area. It is effective in reducing the
probing depth and improving the clinical attachment gain in
the majority of periodontitis cases (Badersten et al., 1984b),
however, other cases like smokers respond less favorably to
non-surgical periodontal therapy (Grossi et al., 1997).
The adjunctive antibiotics are used in Periodontics either as
locally delivered or as systemically delivered agents. The
advantages of locally delivered antibiotics include attaining
higher concentration in the diseased sites which assures the
control of infection, need for one time application only and
the absence of systemic adverse effects. In addition, locally
delivered antibiotics do not require patient compliance (Deo
et al., 2010; Emingil et al., 2008; Golub et al., 2008; Gupta
et al., 2008; Paquette, 2005; Slots and Rams, 1990; Tuter
et al., 2010).
The locally delivered antibiotic agents are available for
periodontal use in different preparations like doxycycline gel
(Garrett et al., 1999). Atridox, a 10% formulation of doxycy-
cline in a bioabsorbable, ‘‘ﬂowable’’ poly-DL-lactide and
N-methyl-2-pyrrolidone mixture delivery system that allows
for controlled release over 7 days. It is safe and can reach
and maintain a high concentration in pockets when comparedto other locally delivered antibiotics (Stoller et al., 1998). It
sustains in the pockets for 7–10 days with minimum alteration
in its concentration (Kim et al., 2004). Doxycycline has other
activities beside its antibacterial property, e.g. anti-inﬂamma-
tory property (Golub et al., 1985).
Only few reports are available on the effect of locally deliv-
ered doxycycline (Atridox) as an adjunctive therapy to scal-
ing and root planing in smokers (Deo et al., 2010; Machion
et al., 2006; Ryder, 2007; Shaddox et al., 2007; Tomasi and
Wennstrom, 2004; Tuter et al., 2010). Therefore, the present
study was done to evaluate the effect of locally delivered doxy-
cycline (10%) with scaling and root planing in the periodontal
treatment of smokers and to compare it with scaling and root
planing alone.2. Subjects and materials
2.1. Study population
The data analyzed in the present report was generated from
patients attending the Periodontic Clinic in the College of
Dentistry, King Saud University, Saudi Arabia. Sixteen male
participants with moderately advanced chronic periodontitis
were enrolled in this clinical study. The clinical trial was car-
ried out as a randomized, split-mouth design. It compared
the clinical parameters response to two different treatment
protocols (scaling and root planing with locally delivered
doxycycline; Atridox (Atridox, Tolmar, Inc. CO 80526,
USA) and scaling and root planing alone) at different time
points; baseline, after 6-weeks and after 12-weeks. The oral
cavity of each patient was divided into two halves; right and
left. Each half received scaling and root planing with or
without locally delivered doxycycline application.
The patients enrolled in the study fulﬁlled the following
inclusion criteria: (1) age between 28 and 60 years; (2) must
be a cigarette smoker for more than 5 years; (3) presence of
moderate to severe chronic periodontitis; (4) the presence of
16 teeth with a minimum of four periodontal pockets of prob-
ing depth of P5 mm and bleeding upon probing in each half
mouth of the posterior teeth and (5) the willingness to partic-
ipate and to follow up until the end of the study. The exclusion
criteria included: (1) periodontal treatment performed in the
6 months prior to baseline examination; (2) use of mouth
washes in the last one month from baseline examination; (3)
presence of signs of aggressive periodontitis; (4) patients with
diabetes mellitus, cardiovascular diseases and those taking
medicines; (5) patients with history of allergy to doxycycline
or (6) history of use of systemic antibiotics before 6 weeks of
the baseline examination or during the study.
All patients were given a verbal explanation of the clinical
trial and an informed written consent was obtained from each
participant. Each patient was educated about the cause of peri-
odontal diseases and proper oral hygiene was instructed.
Figure 1 Mean plaque index at baseline, 6th and 12th week
(SRP, scaling and root planing; D, doxycycline).
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technique, using a toothbrush and using waxed dental ﬂoss
or inter-proximal brush when interdental spaces were present.
Instructions were personalized according to the patient’s need,
with the objective of obtaining the best plaque control.
2.2. Clinical examination
The principal investigator was calibrated to ensure the level of
reproducibility. Duplicate measurements of the probing pocket
depth, gingival recession, taken 1 h apart, were performed in 5
patients in a pre-study training period (Machion et al., 2004).
A total of 780 probed sites were assessed for calibration.
Pearson’s correlation test and Student paired t-test were applied
to verify reproduction of measurements. The examiner was
considered calibrated, once the positive statistically signiﬁcant
correlation was obtained and no statistically signiﬁcant differ-
ences between duplicate measurements were found. Within
1 week, all selected patients were appointed for the baseline clin-
ical examination. The clinical examination was repeated after 6
and 12 weeks after treatment using the Florida probe system
(Florida probe corporation, Gainesville, FL, USA).
Occlusal stents were constructed for upper and lower arches
in each patient mouth. Fixed guiding steering grooves (buccal,
lingual and/or palatal) and interproximal notches were made
on the stent for each tooth included adjacent to the measured
sites. The stents were used at the baseline, after 6 and 12 weeks
examinations.
The clinical parameters examined in the present study in-
cluded: plaque index (PI) according to Silness and Loe
(1964), Bleeding on probing (BOP) (Ainamo and Bay, 1975):
(six sites MB, B, DB, ML, L and DL) were examined on each
tooth. Pocket probing depth (PPD), gingival recession (GR)
and clinical attachment level (CAL) were also measured at
six sites around each tooth (Armitage, 1999).
2.3. Scaling and root planing
For each patient 1–2 days following the baseline data collection,
a fullmouth scaling and root planingwere carried using an ultra-
sonic device and hand instruments until the root surface felt
smooth with the tip of a metallic probe. It was followed by pro-
fessional prophylaxis to remove the stains for each patient
immediately after scaling and root planing. The professional
prophylaxis and oral hygiene instructions were continued for
each patient every 2 weeks during the 12 weeks clinical trial.
Randomization was applied to avoid the bias of scaling and
root planing by the clinician. A prepared sealed envelope was
produced for each patient according to his series number. The
envelope was opened at the day of treatment after the comple-
tion of scaling and root planing; then either the right or left half
was chosen for doxycycline (Atridox

: Atrix Laboratories Ltd.,
London, UK) application.
2.4. Doxycycline (Atridox

) application
For each patient one or two packages of Atridox were used
according to the manufacturers’ instructions. The product
was applied using the cannula in either right or left side of
the mouth (molars and premolars only were used) as indicated
by randomization procedure. The side of drug application waslabeled as Group A (SRP + D) and the contra lateral side as
Group B (SRP). Periodontal dressing (Coe-Pak, GCAmeri-
ca, Inc., Chicago, IL) was used to keep the locally delivered
doxycycline (Atridox) inside the pockets and to make the pa-
tient more comfortable (Garrett, 1999; Stoller et al., 1998).
All patients attended the ﬁrst week follow-up visit. First,
the periodontal dressing and the residual doxycycline product
were removed (Radvar et al., 1996). Then, the evaluation in-
volved a brief history by enquiring about complaints and vi-
sual examination of any soft tissue changes after periodontal
dressing removal. All patients were asked to resume brushing
since then.
2.5. Statistical analysis
The data was analyzed using SPSS software (www.spss.com,
version 10). Patient mean values of plaque index, bleeding
on probing, probing depth, gingival recession and clinical
attachment level were calculated for both groups as a basis
for statistical analysis. Repeated Measures Design of Borferoni
test was used to detect intra-group differences among all peri-
ods. Student’s independent t-test was used to detect inter-
group differences in clinical parameters for each time interval
(baseline, after 6 and 12 weeks). In all inferences, P-value of
<0.05 was accepted as statistical signiﬁcance.
3. Results
Twelve smokers (10 cigarettes per day) with a mean age of
39.43 ± 8.15-years were treated according to study protocol.
Four patients out of the 16 recruited for the study, failed to
continue the follow-ups and were excluded from the study.
3.1. Plaque index and bleeding on probing
The results of the mean plaque index and bleeding on probing
of the two groups at the baseline, 6th and 12th week are pre-
sented in Table 1 andFig. 1. The mean plaque index and bleed-
ing on probing of Group A were signiﬁcantly higher than the
mean plaque index and bleeding on probing of Group B at the
baseline examination (P< 0.05). The mean reduction in
Table 1 Plaque index and bleeding on probing of the two groups (BOP, bleeding on probing; PD, probing depth; GR, gingival
recession; CAL, clinical attachment loss).
Groups Baseline Mean ± SD 6 Weeks Mean ± SD 12 Weeks Mean ± SD
Plaque index A 1.45 ± 0.76a 0.40 ± 0.63b 0.34 ± 0.54b
B 1.30 ± 0.80a 0.41 ± 0.56b 0.32 ± 0.56b
BOP A 0.43 ± 0.49a 0.16 ± 0.36b 0.18 ± 0.38b
B 0.30 ± 0.48 0.14 ± 0.35b 0.17 ± 0.38b
PD (5–6 mm) A 5.35 ± 0.35 3.22 ± 1.28a 3.28 ± 1.14a
B 5.36 ± 0.35 3.47 ± 1.22a 3.17 ± 1.15a
PD (P7 mm) A 8.00 ± 0.96 4.97 ± 1.68a 4.66 ± 1.75a
B 7.72 ± 0.64 4.44 ± 2.26a 4.40 ± 2.01a
GR A 0.39 ± 0.97 0.66 ± 1.17a 0.89 ± 1.34a
B 0.38 ± 0.96 0.66 ± 1.23a 0.93 ± 1.42a
CAL A 3.80 ± 1.75 3.24 ± 1.71b 3.28 ± 1.79b
B 3.78 ± 1.65 3.19 ± 1.62b 3.25 ± 1.64b
a (P< 0.05) Statistically signiﬁcant difference at baseline.
b (P< 0.05) Statistically signiﬁcant change from the baseline visit (intra-group).
Figure 2 Mean clinical attachment loss (CAL) at baseline, 6th
and 12th week (SRP, scaling and root planing; D, doxycycline).
146 H. Al Hulami et al.plaque and bleeding on probing in both groups at 6th and 12th
week was signiﬁcant from the baseline. No signiﬁcant differ-
ences were observed between the groups at 6 and 12 weeks
visits.
3.2. Probing measurements
Table 1 presents the summary results for gingival recession
(GR), probing depth (PD) and clinical attachment loss
(CAL). At baseline, mean GR was 0.39 mm for Group A
and 0.38 mm for Group B. A statistically signiﬁcant increase
was observed after treatment at 6 and 12 weeks in both groups.
The mean pocket probing depth of moderate pockets (sites of
5–6 mm) and deep pockets (P7 mm) were similar at the base-
line and they showed a signiﬁcant reduction (P< 0.05) after
the treatment at the 6th and 12th week visits with no signiﬁ-
cant differences between the two groups (P> 0.05).
At the baseline, similar results of CAL were observed. A
statistically signiﬁcant gain of attachment (Table 2 and Fig
2) was observed after the treatment (P< 0.05) with no signif-
icant difference between the two groups at the 6th and 12th
week visits (P> 0.05). Gain in the attachment of Groups A
and B was the same at the 6th and 12th week (Group A:
0.53 ± 1.04 mm vs. Group B: 0.58 ± 1.11 mm).
4. Discussion
The study used a split-mouth design that has the advantage of
eliminating the inter-individual variables (Imrey, 1986; Radvar
et al., 1996). However, it carries a risk of transferring the testedTable 2 Mean gain of attachment (mm) and SD values of the
two groups.
Groups Baseline to 6-week
Mean ± SD
Baseline to 12-week
Mean ± SD
A 0.53 ± 1.00 0.53 ± 1.04
B 0.59 ± 0.98 0.58 ± 1.11agent from one quadrant to another and may lead to false
results (Jorgensen et al., 2004). To minimize this effect a peri-
odontal dressing was applied on the side of doxycycline
application.
The mouth design and the allocation of the quadrants to
the two groups (Group A: scaling and root planing with locally
delivered doxycycline and, Group B: scaling and root planing
alone) resulted in similar baseline values of the probing pocket
depth, gingival recession and clinical attachment level. Mean
pocket probing depth was 3.41 mm in Group A and 3.40 mm
in Group B, with no signiﬁcant difference between the two
groups. It was similar in the moderate pockets (5–6 mm) and
deep pockets (P7 mm). The gingival recession and clinical
attachment level also showed similar results in the two groups.
However, at the baseline examination, the mean plaque index
and mean bleeding on probing were signiﬁcantly higher in
Group A than mean plaque index and mean bleeding on prob-
ing in Group B.
It was also proved that the topically administered doxycy-
cline could reach the pockets in higher concentrations and
could be maintained for a longer period compared to system-
ically administered doxycycline (Stoller et al., 1998). Higher
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ﬂuid (GCF) enhance their action against microbes (Kim
et al., 2002, 2004) and may mitigate the effects of smoking ef-
fect in the local environment of the pockets (Ryder, 2007).
It is well established in the literature that smokers respond
less favorably to periodontal treatment than non-smokers (Ah
et al., 1994; Kaldahl et al., 1996). Few studies showed that the
use of adjunctive controlled delivery of drugs may improve the
clinical response to periodontal treatment in these patients
(Machion et al., 2004, 2006; Tomasi and Wennstrom, 2004).
Lowenguth and Greenstein (1995) showed a greater reduction
in Porphyromonas gingivalis after 3 months use of adjunctive
tetracycline ﬁbers compared to conventional scaling and root
planing (SRP) alone. However, other studies by Salvi et al.
(2002) and Jorgensen et al. (2004) found no additional reduc-
tions in the subgingival microbiota after treatment with
adjunctive local drugs compared to SRP. The observations
of the present study are in agreement with the later studies
showing no additional beneﬁts of locally applied doxycycline
in smokers. Akalin (2004) evaluated the clinical effects of
doxycycline as adjunctive therapy to scaling and root planing
in the treatment of chronic periodontitis. They showed no sig-
niﬁcant differences between the group of SRP alone and SRP
and doxycycline.
A study by Machion et al. (2004) evaluated the effect of
scaling and root planing with locally delivered doxycycline
(SRP-D) compared to SRP alone in smokers. Their results
showed no additional effect of doxycycline on BOP; however
better results were observed in probing depth. Moderate pock-
ets (sites of 5–6 mm) responded equally at the 6th week, 12th
week and 6th month examinations. In the present study,
slightly better PPD reduction of moderate pockets in Group
A was observed at the 6th week visit but it was not signiﬁcant.
Regarding the 12th week visit, the ﬁndings of the moderate
pockets in the present study are in agreement with the
observations.
The clinical effects of locally delivered doxycycline to
scaling and root planing had been evaluated in several stud-
ies (Akalin, 2004; Eickholz et al., 2002; Gupta et al., 2008;
Machion et al., 2004; Tomasi and Wennstrom, 2004; Tuter
et al., 2010; Wennstrom et al., 2001). These studies had
shown varying results, which can be attributed to the treat-
ment regimens followed. Eickholz et al. (2002) compared in
a split mouth design the SRP alone, SRP with vehicle appli-
cation and SRP with doxycycline application on single
rooted teeth in 3 and 6 months observation period. They re-
ported better results in mean reduction of BOP, mean prob-
ing depth reduction and attachment level gain which favored
the group of SRP and doxycycline application.
The reduction of the probing depth of the pockets post-
periodontal therapy is mainly due to the gain in the clinical
attachment and/or shrinkage in the gingiva. The gingival
shrinkage occurs usually as a result of the instrumentation-
mainly hand instruments (Ewen et al., 1976) and due to res-
olution of the gingival inﬂammation. The mean gingival
recession at the baseline examination of this study was sim-
ilar and increased signiﬁcantly after treatment with no signif-
icant difference between both groups. The reduction of the
pocket probing depth in the present study which continued
from 6th week to 12th week was due to the attachment gain
and the shrinkage of the gingiva. By maintaining a good le-
vel of plaque control, the improvements of the clinicalparameters could be sustained. The proposed treatment
was well tolerated by the patients. Only one patient devel-
oped gingival soreness at the site of doxycycline application
that healed within 10 days. In general, the topical applica-
tion of doxycycline is safe and the observation of the present
study is in agreement with previous reports (Deo et al.,
2010; Eickholz et al., 2002; Golub et al., 2008; Tuter
et al., 2010; Wennstrom et al., 2001). Other patients in both
experimental groups complained from dentinal sensitivity
after the treatment which disappeared within the period of
the study.
It can be concluded that the topical application of doxycy-
cline along with scaling and root planing had no additional
beneﬁts over the mechanical therapy alone.Acknowledgments
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